Granite Point Capital’s Returns, AUM, and Holdings
Warren Lammert founded Granite Point Capital, a long/short hedge fund with a focus on small-cap companies, in January 2004. The fund is headquartered in Boston, Massachusetts, and Mr.
Marinus Pharmaceuticals Inc. (MRNS)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Market Movers Today: Aemetis Inc (AMTX), Ciena Corporation (CIEN), Baytex Energy Corp (BTE), Marinus Pharmaceuticals Inc (MRNS), and More
Shares of biotech Marinus Pharmaceuticals Inc. MRNS, -9.62% slid more than 14% in premarket trade Tuesday, after the company reported a wider-than-expected loss for 2017.
13G Filing: EcoR1 Capital and Marinus Pharmaceuticals Inc (MRNS)
You can access the original SEC filing by clicking here.
13G Filing: Granite Point Capital and Marinus Pharmaceuticals Inc (MRNS)
Granite Point Capital Panacea Global Healthcare Fund, a limited partnership organized under the laws of the State of Delaware ("Panacea Fund") with respect to the shares of Common Stock directly held ...
13G Filing: James E. Flynn and Marinus Pharmaceuticals Inc (MRNS)
You can access the original SEC filing by clicking here.
What Is Going On In The Financial Markets Today?
“U.S. stocks were slightly lower on Friday, dragged down by technology stocks as investors locked in gains of what is likely to be Wall Street's strongest first-quarter performance in four years.
Here's Why Investors Are Watching Sangamo Biosciences, GNC Holdings, and Three Other Stocks Today
Markets are mixed on Wednesday as investors get ready to digest a flurry of earnings, and await Federal Reserve’s summary of commentary of the current economic condition, also known as the “Beige ...
Why These 5 Stocks Are Winning Today
The markets have edged lower today on the final trading day of what has been a very crucial week.
5 Stocks That Have Kicked Off the Week on a Sour Note
Crude futures and all three indexes are lower today as investors remain in a risk-off posture before the FOMC meeting later this week and the Brexit vote on the 23rd of this month.
The Stock Picks of This Obscure Hedge Fund Returned 70.5% In 2015; See What It's Betting On in 2016
Although Los Angeles-based, biotech-focused hedge fund DAFNA Capital Management has been in operation for the past 17 years, chances are that very few people have heard its name.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
